UA48969C2 - Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis - Google Patents

Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis

Info

Publication number
UA48969C2
UA48969C2 UA97125973A UA97125973A UA48969C2 UA 48969 C2 UA48969 C2 UA 48969C2 UA 97125973 A UA97125973 A UA 97125973A UA 97125973 A UA97125973 A UA 97125973A UA 48969 C2 UA48969 C2 UA 48969C2
Authority
UA
Ukraine
Prior art keywords
tbo
demethylation
oxidizing
displastic
derivatives
Prior art date
Application number
UA97125973A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Дуглас Д. Беркетт
Original Assignee
Зіла, Іhк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зіла, Іhк filed Critical Зіла, Іhк
Priority to UA97125973A priority Critical patent/UA48969C2/en
Publication of UA48969C2 publication Critical patent/UA48969C2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The N-demethylation and N,N-demethylation derivatives of the two conformational isomers toluidine blue О ("TBO") have been isolated, identified and prepared. An in vivo biological stain composition includes the conformational isomers of TBO and these N- and N,N-demethylation derivatives. The ratio of these isomers to these demethylation derivatives is at least 6:1. An improved method for detecting displastic oral tissue includes application of such TBO products, in a liquid carrier, to oral tissue. A process for preparing TBO products includes (1) oxidizing N,N-dimethyl--phenylenediamine to form an intermediate 2-amino-5-dimethylaminophenyl thiosulfonic acid, (2) oxidizing this intermediate and condensing the oxidizate with -toluidine, forming indamine thiosulfonic acid and (3) further oxidizing the indamine intermediate to form a TBO-containing reaction product, which is precipitated from the reaction mixture as a complex, from which the final TBO product is separated. The complexing agent is added to the reaction mixture at least before the final oxidation stеp, preferably before the second oxidation step. An HPLC method for characterizing TBO products containing the conformational isomers of TBO and their N-and N,N-demethylation derivatives. A mobile phase comprises an aqueous solution of an organic acid compound.
UA97125973A 1997-12-10 1997-12-10 Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis UA48969C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97125973A UA48969C2 (en) 1997-12-10 1997-12-10 Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97125973A UA48969C2 (en) 1997-12-10 1997-12-10 Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis

Publications (1)

Publication Number Publication Date
UA48969C2 true UA48969C2 (en) 2002-09-16

Family

ID=74293086

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97125973A UA48969C2 (en) 1997-12-10 1997-12-10 Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis

Country Status (1)

Country Link
UA (1) UA48969C2 (en)

Similar Documents

Publication Publication Date Title
Zee-Cheng et al. Antineoplastic agents. Structure-activity relationship study of bis (substituted aminoalkylamino) anthraquinones
De Voss et al. Characterization of the in vitro cyclization chemistry of calicheamicin and its relation to DNA cleavage
MY120842A (en) 1,4-benzothiazepine-1, 1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use.
SG103194G (en) Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound
HUT67390A (en) Tetrazolyl bile acid derivatives, process for producing them and pharmaceutical compositions containing them
YU60701A (en) Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
IL106128A0 (en) Vitamin d derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ME00428B (en) 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
HUP9802577A2 (en) In vivo stain composition, process for manufacture, and methods of use to identify dysplastic tissue
HK1056179A1 (en) Oxidation process for preparing the intermediate 6.alpha., 9.alpha.- difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3- one 17.beta.-carboxylic acid
UA35607C2 (en) oxazolidinonecarboxylic ACID derivatives, a process for the preparation thereof, pharmaceutical composition and a method for the preparation thereof
AU5835400A (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and process for the preparation of the active substance
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
UA48969C2 (en) Stain compositions in vivo, method of their production, method of use for identification of displastic tissue, hplc method of analysis
CA2250731A1 (en) In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
DE50204789D1 (en) NEW 1-AMIDOMETHYL CARBONYL-PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
DE60041137D1 (en) CERAMID SIMILAR COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS ANTITUMUM AGENT
DE69917668D1 (en) SUBSTANCE GM-95, METHOD FOR THEIR PRODUCTION AND THEIR USE
HUP9902783A2 (en) Polymorph of zopolrestat monohydrate, process for it's preparation and therapical use of the same
AP2002002572A0 (en) Novel substituted pyrazol(4,3-e) diazepines, pharmaceutical compositions containing them, as medical products and processes for preparing them
Rizk et al. Fluorimetric determination of nalidixic acid in formulations and biological fluids through ternary complex formation
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
WO2003004460A3 (en) Succinic acid derivatives
IL94051A0 (en) 1-normon-2-yl-heterocycles,process for their preparation and pharmaceutical compositions containing them